Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?

The oncologist

Volumn 15 Suppl 3, Issue , 2010, Pages 8-12

  Paccagnella, Adriano ^a   Mastromauro, Cataldo ^b   D'Amanzo, Paola ^b   Ghi, Maria Grazia ^b  

^a Serv Gastroenterologia E   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL; TAXOID;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK TUMOR; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; TAXOIDS; UNITED STATES;

EID: 79959531350     PISSN: None     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-S3-08     Document Type: Article

References (0)